Revvity says it will exceed 2025 profit forecast range

Core Viewpoint - Revvity expects its 2025 adjusted profit per share to exceed the forecast of $4.90 to $5, driven by renewed demand for contract research and diagnostics services [1] Company Summary - Revvity is a medical equipment maker that is experiencing a positive shift in demand for its services [1]